Assessment of adverse drug reactions in psychiatric inpatients with the AMSP drug safety program: methods and first results for tricyclic antidepressants and SSRI.

@article{Grohmann1999AssessmentOA,
  title={Assessment of adverse drug reactions in psychiatric inpatients with the AMSP drug safety program: methods and first results for tricyclic antidepressants and SSRI.},
  author={Renate Grohmann and Eckart Ruether and Rolf R. Engel and Hanns Hippius},
  journal={Pharmacopsychiatry},
  year={1999},
  volume={32 1},
  pages={21-8}
}
The AMSP (Arzneimittelsicherheit in der Psychiatrie) study is a new program for continuous assessment of adverse drug reactions (ADR) in psychiatric inpatients under naturalistic conditions of routine clinical treatment. It is based on the preceding drug surveillance study AMUP (Arzneimittelüberwachung in der Psychiatrie). Currently, 29 hospitals are participating in the study. This paper reports on the methods of the AMSP study and the first findings on the comparative risks of tricyclic… CONTINUE READING
7 Citations
0 References
Similar Papers